Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
34
IAS Quote, Financials, Valuation and Earnings
Last price:
$10.34
Seasonality move
:
-8.81%
Day range:
$10.34 - $10.34
52-week range:
$6.26 - $11.43
Dividend yield:
0%
P/E ratio:
37.05x
P/S ratio:
2.93x
P/B ratio:
1.57x
Volume:
--
Avg. volume:
1.2M
1-year change:
-1.16%
Market cap:
$1.7B
Revenue:
$530.1M
EPS (TTM):
$0.28
Earnings Data
Next earnings date for IAS
Feb 26
2026
Most recent earnings per share
$0.04
Missed by $0.16
(Nov 4/2025)
Consensus Estimate
$0.20
(Nov 4/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
IAS Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/26/2026 | Q4 | $170.1M | -- | -- | $0.27 | -- |
| 11/04/2025 | Q3 | $149.2M | $154.4M | $0.04 | $0.20 | -$0.16 |
| 08/07/2025 | Q2 | $143.6M | $149.2M | $0.10 | $0.17 | -$0.07 |
| 05/12/2025 | Q1 | $129.3M | $134.1M | $0.05 | $0.14 | -$0.09 |
| 02/28/2025 | Q4 | $148.8M | $153M | $0.09 | $0.25 | -$0.16 |
| 11/12/2024 | Q3 | $138.1M | $133.5M | $0.10 | $0.19 | -$0.09 |
| 08/01/2024 | Q2 | $126.3M | $129M | $0.05 | $0.15 | -$0.10 |
| 05/09/2024 | Q1 | $112.1M | $114.5M | -$0.01 | $0.10 | -$0.11 |
| 02/27/2024 | Q4 | $131.3M | $134.3M | $0.06 | $0.21 | -$0.14 |
| 11/02/2023 | Q3 | -- | $120.3M | -$0.09 | -- | -- |
| 08/03/2023 | Q2 | -- | $113.7M | $0.05 | -- | -- |
| 05/04/2023 | Q1 | -- | $106.1M | $0.02 | -- | -- |
| 03/02/2023 | Q4 | -- | $117.4M | $0.07 | -- | -- |
| 11/10/2022 | Q3 | -- | $101.3M | $0.00 | -- | -- |
| 08/04/2022 | Q2 | -- | $100.3M | $0.01 | -- | -- |
| 05/11/2022 | Q1 | -- | $89.2M | $0.01 | -- | -- |
| 03/03/2022 | Q4 | -- | $102.5M | -$0.03 | -- | -- |
| 11/10/2021 | Q3 | -- | $79M | -$0.06 | -- | -- |
| 08/12/2021 | Q2 | -- | $75.1M | -$0.26 | -- | -- |
| 03/31/2021 | Q1 | -- | $67M | -$0.02 | -- | -- |
| 12/31/2020 | Q4 | -- | $78.3M | $0.02 | -- | -- |
| 09/30/2020 | Q3 | -- | $60M | -$0.03 | -- | -- |
| 06/30/2020 | Q2 | -- | $48.3M | -$0.11 | -- | -- |
| 03/31/2020 | Q1 | -- | $54M | -$0.10 | -- | -- |
| 12/31/2019 | Q4 | -- | $64M | -$0.08 | -- | -- |
| 09/30/2019 | Q3 | -- | $52.2M | -$0.07 | -- | -- |
| 06/30/2019 | Q2 | -- | $52.2M | -$0.09 | -- | -- |
| 03/31/2019 | Q1 | -- | $45.1M | -$0.10 | -- | -- |
Integral Ad Science Holding Corp. Earnings Questions
-
How Much did Integral Ad Science Holding Corp. Generate in Revenue Last Quarter?
Integral Ad Science Holding Corp. reported $154.4M worth of top line sales in its most recent quarter.
-
Did Integral Ad Science Holding Corp. Beat Earnings Last Quarter?
Integral Ad Science Holding Corp. announced earnings per share of $0.04 which represents a miss of analyst forecast a $0.20 per share.
-
Is Integral Ad Science Holding Corp. Profitable?
Integral Ad Science Holding Corp. reported $100.9M that represents $0.59 per share over the last quarter.
-
What is the Analyst Consensus for Integral Ad Science Holding Corp. EPS Next Year?
Integral Ad Science Holding Corp.'s earnings are forecast to grow from $0.23 per share to $0.82 per share next year representing an increase of 338.7%.
-
When is Integral Ad Science Holding Corp.'s Earnings Date?
Integral Ad Science Holding Corp.'s next earnings date is February 26, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 24
Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.
Buy
85
HUT alert for Dec 24
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
63
GPCR alert for Dec 24
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
